article thumbnail

Gene therapy specialist bluebird exits “untenable” European market

pharmaphorum

The decision was taken by the UUS regulator after a case of a rare blood cancer (myelodysplastic syndrome) was seen in a patient treated with Skysona that probably arose as a result of the lentiviral vector used to deliver the gene therapy.

article thumbnail

Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year

The Pharma Data

Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial

pharmaphorum

The two partners have revealed the first clinical data from a phase 2b trial of a personalised vaccine consisting of 34 mRNAs, each targeting mutations – identified by gene sequencing – that are thought to be driving a patient’s cancer. They also said they plan to discuss the phase 2b results with regulators.

Vaccine 98
article thumbnail

Rising Demand for DNA and Gene Cloning  Service Providers

Roots Analysis

DNA and Gene Cloning involves the isolation of a DNA sequence of any species ( often a gene ) and its insertion into a vector to enable growth without any alteration in the original DNA sequence. DNA cloning is a largely accepted technique, however, it has been regulated carefully.

DNA 40
article thumbnail

Medicago, GSK’s plant-made COVID jab clears phase 2

pharmaphorum

The advantage of plant-based production is that it is quick – Medicago says it produced the main ingredient for its vaccine just 20 days after the gene sequence of SARS-CoV-2 was published – and is easily scalable simply by cultivating additional plants.

Vaccine 64